Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.50 |
| ▸ | NMT2 | O60551 | 1/20 | 0.49 |
| ▸ | NMT1 | P30419 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | GCGR | P47871 | 1/20 | 0.47 |
| ▸ | DRD2 | P14416 | 1/20 | 0.46 |
| ▸ | DRD1 | P21728 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
| ▸ | CACNA1F | O60840 | 5/20 | 0.46 |
| ▸ | CACNA1D | Q01668 | 5/20 | 0.46 |
| ▸ | CACNA1S | Q13698 | 5/20 | 0.46 |
| ▸ | CACNA1C | Q13936 | 5/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL10527368 | 0.99 | PTPN1 (0.49) | PTPN1NMT2NMT1MEN1GAA | |
| SCHEMBL9788511 | 0.92 | ALDH1A1 (0.52) | NMT2NMT1MEN1GAAKMT2A | |
| SCHEMBL10526571 | 0.91 | NMT2 (0.44) | PTPN1NMT2NMT1MEN1GAA | |
| SCHEMBL9788507 | 0.91 | ABCB1 (0.52) | PTPN1NMT2NMT1MEN1GAA | |
| Hydrochloric Acid SCHEMBL9788535 | 0.91 | ALDH1A1 (0.51) | NMT2NMT1MEN1GAAKMT2A | |
| SCHEMBL9788513 | 0.91 | NMT2 (0.47) | PTPN1NMT2NMT1MEN1GAA | |
| Hydrochloric Acid SCHEMBL9788506 | 0.90 | NMT2 (0.46) | PTPN1NMT2NMT1MEN1GAA | |
| SCHEMBL9788539 | 0.85 | DRD2 (0.54) | MEN1GAAKMT2ATDP1GCGR | |
| SCHEMBL6984399 | 0.77 | KDM4E (0.56) | PTPN1NMT2NMT1MEN1GAA | |
| SCHEMBL10592149 | 0.73 | KDM4E (0.43) | NMT2NMT1CACNA1FCACNA1DCACNA1S |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0347932-A2 | Treatment of conditions requiring enhanced oxygen availability to mammalian tissues | RORER INTERNATIONAL (OVERSEAS) INC. (US) | 1989-12-27 | — | — | EP | claimed |